TY - JOUR
T1 - Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus
AU - Jiang, Z.
AU - Kunimoto, M.
AU - Patel, J. A.
PY - 1998
Y1 - 1998
N2 - The mechanisms of regulation of interleukin-6 (IL-6) production in respiratory syncytial virus (RSV)-infected respiratory epithelial cells were evaluated in A549 cell cultures. Incubation with purified RSV resulted in significant production of IL-1α, IL-1β, IL-6, and tumor necrosis factor alpha (TNF-α). Addition of saturating concentrations of neutralizing antibodies against IL-1α, IL-1β, or TNF-α into purified RSV-infected cell cultures resulted in a significant inhibition of IL-6 production, although anti-IL-1α antibody had the most predominant effect (80% inhibition). Anti- IL-1α antibody also almost completely blocked the expression of mRNA for IL- 6. Addition of therapeutic concentrations of dexamethasone (1 μM) or ribavirin (90 μg/ml), an antiviral agent, also significantly inhibited the synthesis of IL-6. Hence, in clinical settings, pharmacological agents such as the specific antagonists of IL-6-inducing cytokines, as well as dexamethasone and ribavirin, could be used to modulate IL-6 production.
AB - The mechanisms of regulation of interleukin-6 (IL-6) production in respiratory syncytial virus (RSV)-infected respiratory epithelial cells were evaluated in A549 cell cultures. Incubation with purified RSV resulted in significant production of IL-1α, IL-1β, IL-6, and tumor necrosis factor alpha (TNF-α). Addition of saturating concentrations of neutralizing antibodies against IL-1α, IL-1β, or TNF-α into purified RSV-infected cell cultures resulted in a significant inhibition of IL-6 production, although anti-IL-1α antibody had the most predominant effect (80% inhibition). Anti- IL-1α antibody also almost completely blocked the expression of mRNA for IL- 6. Addition of therapeutic concentrations of dexamethasone (1 μM) or ribavirin (90 μg/ml), an antiviral agent, also significantly inhibited the synthesis of IL-6. Hence, in clinical settings, pharmacological agents such as the specific antagonists of IL-6-inducing cytokines, as well as dexamethasone and ribavirin, could be used to modulate IL-6 production.
UR - http://www.scopus.com/inward/record.url?scp=0031951652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031951652&partnerID=8YFLogxK
U2 - 10.1128/jvi.72.3.2496-2499.1998
DO - 10.1128/jvi.72.3.2496-2499.1998
M3 - Article
C2 - 9499112
AN - SCOPUS:0031951652
SN - 0022-538X
VL - 72
SP - 2496
EP - 2499
JO - Journal of virology
JF - Journal of virology
IS - 3
ER -